CY1115894T1 - USES OF INTERFERENCE WITH MODIFIED SPACE - Google Patents
USES OF INTERFERENCE WITH MODIFIED SPACEInfo
- Publication number
- CY1115894T1 CY1115894T1 CY20151100043T CY151100043T CY1115894T1 CY 1115894 T1 CY1115894 T1 CY 1115894T1 CY 20151100043 T CY20151100043 T CY 20151100043T CY 151100043 T CY151100043 T CY 151100043T CY 1115894 T1 CY1115894 T1 CY 1115894T1
- Authority
- CY
- Cyprus
- Prior art keywords
- interference
- hypersensitivity
- subject
- effective amount
- provides
- Prior art date
Links
Abstract
Η παρούσα εφεύρεση παρουσιάζει μια μέθοδο για την πρόληψη ή την αντιμετώπιση του Σοβαρού Οξέος Αναπνευστικού Συνδρόμου σε ένα υποκείμενο, η οποία περιλαμβάνει τη χορήγηση στο υποκείμενο μιας αποτελεσματικής ποσότητας της ανασυνδυασμένης υπερένωσης ιντερφερόνης ή ενός λειτουργικού ισοδύναμου αυτής. Η παρούσα εφεύρεση παρέχει μια μέθοδο για την αναστολή του νοσογόνου παράγοντα του Σοβαρού Οξέος Αναπνευστικού Συνδρόμου που περιλαμβάνει την επαφή του παράγοντα με μια αποτελεσματική ποσότητα της υπερένωσης ιντερφερόνης ή του ισοδυνάμου αυτής.The present invention provides a method for preventing or treating Severe Acute Respiratory Syndrome in a subject, comprising administering to the subject an effective amount of recombinant interferon hypersensitivity or a functional equivalent thereof. The present invention provides a method for inhibiting the Serious Acid Respiratory Syndrome pathogenic agent comprising contacting the agent with an effective amount of interferon hypersensitivity or its equivalent.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49844903A | 2003-08-28 | 2003-08-28 | |
US49878503A | 2003-08-28 | 2003-08-28 | |
US49892303A | 2003-08-28 | 2003-08-28 | |
IN280MU2004 | 2004-03-05 | ||
IN279MU2004 | 2004-03-05 | ||
EP10193126.9A EP2325202B1 (en) | 2003-08-28 | 2004-08-26 | Uses of interferons with altered spatial structure |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115894T1 true CY1115894T1 (en) | 2017-01-25 |
Family
ID=58457107
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100200T CY1114971T1 (en) | 2003-08-28 | 2014-03-13 | USES OF INTERFERENCE WITH MODIFIED SPACE |
CY20151100043T CY1115894T1 (en) | 2003-08-28 | 2015-01-16 | USES OF INTERFERENCE WITH MODIFIED SPACE |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100200T CY1114971T1 (en) | 2003-08-28 | 2014-03-13 | USES OF INTERFERENCE WITH MODIFIED SPACE |
Country Status (1)
Country | Link |
---|---|
CY (2) | CY1114971T1 (en) |
-
2014
- 2014-03-13 CY CY20141100200T patent/CY1114971T1/en unknown
-
2015
- 2015-01-16 CY CY20151100043T patent/CY1115894T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CY1114971T1 (en) | 2016-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121853T1 (en) | COMBINATION THERAPY FOR THE MANAGEMENT OF DIABETES | |
CY1120079T1 (en) | Aqueous Composition Containing Bromexine | |
CY1117033T1 (en) | TREATMENT AGAINST ACUTE LEMBLASTIC LEFT | |
CY1120961T1 (en) | ORAL DOSAGE CONTAINERS INCLUDING ANTI-PETROLEUM PATENT AND ACID INHIBITOR | |
CY1111926T1 (en) | COOPERATIVE COMPOSITIONS WITH FK-228 | |
CY1109295T1 (en) | METHODS FOR TREATMENT OF PARKINS DISEASE | |
CY1121125T1 (en) | COMPOSITIONS FOR THE TREATMENT OF PAIN AND / OR INFLAMMATION | |
CY1110177T1 (en) | Z-CARBONYLSYL SUBSTITUTED BISINSULARS AS RAF MOTION INHIBITORS | |
CY1120022T1 (en) | Pediatric Acute Acute Lymphoblastic Leukemia Treatment | |
EA200601553A1 (en) | SUBSTITUTED BENZIMIDAZOLE-, BENZTRIASOLE- AND BENZIMIDAZOLONE-O-GLUCOSIDES | |
CY1118731T1 (en) | ALVIGLUTIDIS PHARMACEUTICAL COMPOSITIONS | |
CY1119488T1 (en) | BASES FOR TREATMENT Ή / AND PREVENTION OF SLEEP DISORDER | |
EA200870357A1 (en) | DERIVATIVES OF TETRAHYDROISOHINOLINE FOR IMPROVING MEMORY FUNCTION | |
CY1111225T1 (en) | NEW Peptides As NS3-Serine Protease Inhibitors Inhibit C | |
CY1112185T1 (en) | STABLE COMPOUND OF ACTIVE SUBSTANCES FROM SALTS OF O-ACETYLSACYLIC ACIDS WITH BASIC AMINO ACIDS AND GLYCIN | |
EA201500802A1 (en) | METHODS OF PREVENTION AND / OR TREATMENT OF CARDIOMYOPATHY AND ELIMINATION OF CARDIOMYOPATHY SYMPTOMS, PHARMACEUTICAL COMPOSITION, VECTORS | |
MX341883B (en) | Pharmaceutical composition for treatment and prevention of cancer. | |
EA202091114A1 (en) | NEW HIGHLY ACTIVE PYRAZOLOPIPERIDINE-SUBSTITUTED INDOL-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV) | |
CY1113485T1 (en) | SUBSTITUTED-CINOXALINE TYPES OF POWERED-Piperidine Compounds and Their Uses | |
CY1119850T1 (en) | USE OF METFORMIN IN COMBINATION WITH AN INTERACTIVE GLYKINASE AND COMPOSITIONS INCLUDING METFORMIN AND ACTIVATOR | |
CY1116374T1 (en) | TREATMENT FOR INFECTION WITH USITIS B alone or in combination with USITA virus delta and related US diseases | |
CY1115081T1 (en) | NEW EXTRACT FROM GAIDOURAGATHO, METHOD FOR PREPARATION AND USE | |
CY1112614T1 (en) | TREATMENT WITH TREATMENT FOR MULTIPLE SCLEROSIS | |
CY1118967T1 (en) | HIGH-DOSE BIOTINE PHARMACEUTICAL COMPOSITIONS | |
EA200702336A1 (en) | APPLICATION 24-NorUDK |